Pillar Biosciences

Natick, MA · Founded 2014 · Privately Held (backing)

Developer of a next-generation sequencing platform designed to support treatment selection through accurate testing across different stages of cancer care. Pillar Biosciences is based in Natick, MA and was founded in 2014. It was valued at $309 million at its later-stage round in May 2025, the last priced event on record. It has raised $121 million across 2 recorded rounds; the latest was a $20 million early-stage round in May 2021.

PMV mark · valuation
$309.0M
Oct 2026
Priced at
its later-stage round
May 2025
Total raised
$120.9M
Last round
Early Stage VC
May 2021
What is Pillar Biosciences worth?
$309.0MPrivateMarketView mark · Oct 2026

Valued at $309.0M at its later-stage round, May 2025. Nothing has traded since.

Free account
More of Pillar Biosciences with a free account
  • ·Watch Pillar Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Pillar Biosciences funding history

2 rounds
DateRoundRaisedPost-money
May 2021Early Stage VC$20.0M▮
Feb 2020Early Stage VC$18.0M▮
Unlock post-money valuations

Membership and data by Private Market View

Pillar Biosciences valuation

Pillar Biosciences was valued at $309 million at its later-stage round in May 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Pillar Biosciences raised?

Pillar Biosciences has raised $121 million in total; 2 of its rounds are on record. The largest on record was a $20 million early-stage round in May 2021.

Pillar Biosciences has filed 2 Form Ds with the SEC since 2020, most recently in Jun 2021 ($20 million sold to 1 investor).

How Pillar Biosciences's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Pillar Biosciences, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Pillar Biosciences

What is Pillar Biosciences worth?
Pillar Biosciences is valued at $309.0M as of Oct 2026. Valued at $309.0M at its later-stage round, May 2025. Nothing has traded since.
How much has Pillar Biosciences raised?
Pillar Biosciences has raised $120.9M in total funding across 2 recorded rounds.
When did Pillar Biosciences last raise?
Pillar Biosciences last raised in May 2021 (Early Stage VC), raising $20.0M.